FAM168B is a favorable prognostic indicator in renal cancer and is known as a negative regulator of CDC42 and a positive regulator of CDC27 (https://www.proteinatlas.org/ENSG00000152102-FAM168B [45]). Here, FAM168B is linked to renal carcinoma.